Perrigo Expands Smoking Cessation Line As Private Label Burns Up Category
This article was originally published in The Pink Sheet
Executive Summary
Perrigo launches a private label version of Nicorette White Ice Mint Gum, a product it says generates nearly $80m in annual sales. Private label leads the smoking cessation category, with GSK the leading branded marketer.
You may also be interested in...
Perrigo Starts Branded Consumer Product Rescue Mission In Belgium
Perrigo is restructuring its OTC drug and nutritional product businesses in Belgium – Omega Pharma Belgium NV, Etixx NV and Biover NV – and expects changes will eliminate between 45 and 80 jobs.
In Brief
Novartis ships Excedrin Migraine; Perrigo will launch mini nicotine lozenges; Matrixx ups offer to buy ProPhase; Merck consolidates HQ in Summit, N.J.; NBTY expects at least 3% sales boost; FDA will hold risk communication meeting; more news In Brief.
MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In
The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.